| __timestamp | Bio-Techne Corporation | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 13673000 |
| Thursday, January 1, 2015 | 40853000 | 14358000 |
| Friday, January 1, 2016 | 45187000 | 12203000 |
| Sunday, January 1, 2017 | 53514000 | 18125000 |
| Monday, January 1, 2018 | 55329000 | 17071000 |
| Tuesday, January 1, 2019 | 62413000 | 20018000 |
| Wednesday, January 1, 2020 | 65192000 | 32788000 |
| Friday, January 1, 2021 | 70603000 | 44966000 |
| Saturday, January 1, 2022 | 87140000 | 311681000 |
| Sunday, January 1, 2023 | 92493000 | 77707000 |
| Monday, January 1, 2024 | 96664000 |
Cracking the code
In the ever-evolving world of biotechnology, research and development (R&D) is the lifeblood that fuels innovation and growth. Over the past decade, Bio-Techne Corporation and Lantheus Holdings, Inc. have demonstrated distinct strategies in their R&D investments. From 2014 to 2023, Bio-Techne consistently increased its R&D spending, peaking at nearly 97 million in 2023, a threefold increase from 2014. This steady growth underscores their commitment to innovation.
Conversely, Lantheus Holdings, Inc. exhibited a more volatile R&D trajectory. Notably, in 2022, their R&D expenses surged to over 311 million, a staggering 22-fold increase from 2014, before dropping to 78 million in 2023. This fluctuation suggests a strategic pivot or a response to market demands. As we look to the future, these investment patterns offer a glimpse into each company's priorities and potential breakthroughs.
Comparing Innovation Spending: Novo Nordisk A/S and Bio-Techne Corporation
Comparing Innovation Spending: Johnson & Johnson and Bio-Techne Corporation
R&D Spending Showdown: Amgen Inc. vs Lantheus Holdings, Inc.
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Bio-Techne Corporation
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Bio-Techne Corporation
Bio-Techne Corporation vs Lantheus Holdings, Inc.: Efficiency in Cost of Revenue Explored
Bio-Techne Corporation vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
R&D Insights: How Bio-Techne Corporation and Wave Life Sciences Ltd. Allocate Funds